GENEREX BIOTECHNOLOGY CORP | Business Contracts

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on September 3, 2020)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 3, 2020)

MASTER SERVICES AGREEMENT (Filed With SEC on March 17, 2020)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on September 3, 2020)

NOTESETTLEMENT AGREEMENT (Filed With SEC on August 11, 2020)

Form of Series C Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series B Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series A Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series D Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

THEISSUE PRICE OF THIS NOTE IS $100,000.00 (Filed With SEC on June 22, 2020)

THEISSUE PRICE OF THIS NOTE IS $50,000.00 (Filed With SEC on June 22, 2020)

APPENDIXA- Statement of Work (Filed With SEC on June 8, 2020)

LaboratoryServices AGreement (Filed With SEC on June 8, 2020)

X = Y (A-B) A (Filed With SEC on February 18, 2020)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 18, 2020)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 18, 2020)

Exhibit 3 Transfer Agent Instructions GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 18, 2020)

WHEREAS: (Filed With SEC on February 18, 2020)

AMENDMENT AGREEMENT (Filed With SEC on January 28, 2020)

STOCK PURCHASE AGREEMENT CONFIDENTIAL DRAFT: for discussion Purposes ONLY (Filed With SEC on November 27, 2019)

AGREEMENT: (Filed With SEC on July 16, 2019)

RECITALS: (Filed With SEC on July 16, 2019)

RESTRUCTURING AGREEMENT (Filed With SEC on April 4, 2019)

BACKGROUND (Filed With SEC on February 22, 2019)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 22, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 22, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 22, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 15, 2019)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 15, 2019)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 15, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2019)

AMENDMENT AGREEMENT (Filed With SEC on January 22, 2019)

MANAGEMENT SERVICES AGREEMENT (Filed With SEC on January 11, 2019)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on January 11, 2019)

AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (Filed With SEC on January 11, 2019)

PROMISSORY NOTE CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)

PROMISSORY NOTE (Filed With SEC on January 11, 2019)

PLEDGE AND SECURITY AGREEMENT CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 11, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)

GENEREX BIOTECHNOLOGY CORP (44)